Colestimide co-administered with atorvastatin attenuates the progression of vascular calcification in haemodialysis patients.
Nitta
Kosaku
K
Akiba
Takashi
T
Nihei
Hiroshi
H
D000837:Anion Exchange Resins / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D001808:Blood Vessels / Q000473:pathology*; D002114:Calcinosis / Q000517:prevention & control*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D004811:Epichlorohydrin; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles; D011446:Prospective Studies; D011758:Pyrroles / Q000627:therapeutic use*; D006435:Renal Dialysis; D012117:Resins, Synthetic
D000837:Anion Exchange Resins; D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D007093:Imidazoles; D011758:Pyrroles; D012117:Resins, Synthetic; C417427:colestimide; D004811:Epichlorohydrin; D000069059:Atorvastatin